Correlation between sRAGE levels and pulmonary dysfunction and inflammatory response in CS exposed 120 day group mice. by Yue He (385239)

Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

Residual stress of various samples: (a) surface residual stress and (b) residual stress in the depth direction. by Huashen Guan (20454677)

rTsSPc interacted with PGAM5 and increased its protein expression in Caco-2 cells. by Qi Qi Lu (17721401)

Initial participants by wave*. by Yeo Ju Sohn (18536198)

“…Trend tests indicated a substantial decrease in the OR as the relative HGS increased for male and total groups (p for trend < 0.05).…”

General characteristics of research participants. by Yeo Ju Sohn (18536198)

“…Trend tests indicated a substantial decrease in the OR as the relative HGS increased for male and total groups (p for trend < 0.05).…”

Seven forecast scenarios. by Ryan P. Thombs (9138968)

“…We estimate error correction models, which we ensure are free from residual autocorrelation and structural breaks. We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …”

Forecast for each scenario, 2023-2032. by Ryan P. Thombs (9138968)

“…We estimate error correction models, which we ensure are free from residual autocorrelation and structural breaks. We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …”

Coefficient plot of short-run effects. by Ryan P. Thombs (9138968)

Coefficient plot of long-run effects. by Ryan P. Thombs (9138968)

Microstructure of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

Data sample demographics. Note that AP refers to anti-psychotic medication, and AD refers to anti-depressive medication. Thus, AP and AD in this table refer to the percentage of pa... by Eloy Geenjaar (21533195)

CVD and mortality outcomes hazard ratio (HR) by years since quit smoking among former smokers compared with current and never smokers. by Erfan Tasdighi (9144667)

Association between smoking status and incidence of cardiovascular and mortality outcomes stratified by enrollment year. by Erfan Tasdighi (9144667)

Baseline characteristics across conventional cigarette use status. by Erfan Tasdighi (9144667)

Association between smoking status and incidence of cardiovascular and mortality outcomes among men. by Erfan Tasdighi (9144667)

Association between the number of cigarettes per day with cardiovascular outcomes among current cigarette users. by Erfan Tasdighi (9144667)

Cessation duration and pack-years concurrent effect on the hazard ratio (HR) for cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

Association between smoking Status and Incidence of cardiovascular and mortality outcomes among women. by Erfan Tasdighi (9144667)

Graded association between pack-year groups in former and current smokers and cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)